Cystatin C is a predictor for long-term All-Cause and Cardiovascular Mortality in US Adults with Metabolic Syndrome. Journal Abstract

Cystatin C is a predictor for long-term All-Cause and Cardiovascular Mortality in US Adults with Metabolic Syndrome.

Full Text Sources

Authors

Xiaoying Song; Lijiao Xiong; Tianting Guo; Xue Chen; Pinjun Zhang; Xiaoan Zhang; Zhen Liang

Abstract

OBJECTIVE

This study examined the relationship between Cystatin C (CysC) levels and all-cause, CVD, and cancer mortality in US metabolic syndrome (MetS) patients.

Source

The Journal of clinical endocrinology and metabolism

Pub Types(s)

Journal Article

Language

English

PubMed ID

38597157